RBM to Pay Luminex $12.5M to Settle Dispute, Raises $25M in Private Funding
Multiplexed biomarker testing lab Rules Based Medicine will pay Luminex $12.5 million to settle a lawsuit having to do with Biophysical Corporation’s testing services, Luminex said this week.
RBM, which was spun off from Luminex in September 2002, initially filed the claims in a Travis County, Texas, District Court in 2005, but Luminex soon afterward responded with its own counterclaims.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.